Michael Schmidt

Work

Analyst Michael Schmidt works at GUGGENHEIM and is focused on the Healthcare sector with 326 price targets and ratings documented since 2013 spanning on 29 stocks. Previously, Michael Schmidt worked at LEERINK. Analyst's average stock valuation to be materialised ratio is 60.57% with an average time for price targets to be met of 203.75 days.

Most recent stock forecast was given on BGNE, BeiGene, Ltd at 20-Jan-2023.

Michael Schmidt best performing recommendations are on IONS (IONIS PHARMACEUTICALS, INC).
The best stock recommendation documented was for IONS (IONIS PHARMACEUTICALS, INC) at 7/14/2016. The price target of $26 was fulfilled within 1 day with a profit of $1.48 (6.04%) receiving and performance score of 60.36.

Average potential price target upside

CLVS EXEL FPRX IMMU IMRX MRTX RLAY AGIO BLUE BPMC DRNA IMGN INCY FATE GMAB IONS ORIC PBYI RAIN ACET RUBY TPTX XNCR SGEN ALKS ALNY ZNTL BGNE DCPH

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

9 months 1 days ago

0/5 (0%)

$9.4 (88.90%)

Hold

1 years 3 months 3 days ago

10/11 (90.91%)

$-0.17 (0.33%)

77

Sell

5

$4.88 (4066.67%)

4

1 years 10 months 18 days ago

4/6 (66.67%)

$7.88 (-2.48%)

175

Sell

3

$2.88 (2400.00%)

4

2 years 3 months ago

5/7 (71.43%)

$6.24 (-4.76%)

220

Sell

3

$2.89 (2627.27%)

3 years 3 months 29 days ago

3/3 (100%)

$2.54 (3.65%)

72

Show more analysts
CLVS EXEL FPRX IMMU IMRX MRTX RLAY AGIO BLUE BPMC DRNA IMGN INCY FATE GMAB IONS ORIC PBYI RAIN ACET RUBY TPTX XNCR SGEN ALKS ALNY ZNTL BGNE DCPH